Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 349

1.

Idiopathic inflammatory myopathy: Interrater variability in muscle biopsy reading.

Olivier PA, De Paepe B, Aronica E, Berfelo F, Colman R, Amato A, Dimitri D, Gallardo E, Gherardi R, Goebel HH, Hilton-Jones D, Hofer M, Holton J, Schrøder HD, Selcen D, Stenzel W, de Visser M, De Bleecker JL.

Neurology. 2019 Aug 27;93(9):e889-e894. doi: 10.1212/WNL.0000000000008005. Epub 2019 Jul 29.

PMID:
31358616
2.

Macrophagic myofasciitis-associated dysfunctioning: An update of neuropsychological and neuroimaging features.

Aoun Sebaiti M, Abrivard M, Blanc-Durand P, Van Der Gucht A, Souvannanorath S, Kauv P, Gherardi RK, Itti E, Authier FJ.

Best Pract Res Clin Rheumatol. 2018 Oct;32(5):640-650. doi: 10.1016/j.berh.2019.04.003. Epub 2019 Apr 24. Review.

PMID:
31203922
3.

Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system.

Gherardi RK, Crépeaux G, Authier FJ.

Autoimmun Rev. 2019 Jul;18(7):691-705. doi: 10.1016/j.autrev.2019.05.006. Epub 2019 May 4. Review.

PMID:
31059838
4.

Distinct interferon signatures stratify inflammatory and dysimmune myopathies.

Rigolet M, Hou C, Baba Amer Y, Aouizerate J, Periou B, Gherardi RK, Lafuste P, Authier FJ.

RMD Open. 2019 Feb 26;5(1):e000811. doi: 10.1136/rmdopen-2018-000811. eCollection 2019.

5.

A large multicenter study of pediatric myotonic dystrophy type 1 for evidence-based management.

Lagrue E, Dogan C, De Antonio M, Audic F, Bach N, Barnerias C, Bellance R, Cances C, Chabrol B, Cuisset JM, Desguerre I, Durigneux J, Espil C, Fradin M, Héron D, Isapof A, Jacquin-Piques A, Journel H, Laroche-Raynaud C, Laugel V, Magot A, Manel V, Mayer M, Péréon Y, Perrier-Boeswillald J, Peudenier S, Quijano-Roy S, Ragot-Mandry S, Richelme C, Rivier F, Sabouraud P, Sarret C, Testard H, Vanhulle C, Walther-Louvier U, Gherardi R, Hamroun D, Bassez G.

Neurology. 2019 Feb 19;92(8):e852-e865. doi: 10.1212/WNL.0000000000006948. Epub 2019 Jan 18.

PMID:
30659139
6.

Retraction Notice to "Letter to the editor".

Crépeaux G, Exley C, Shaw CA, Gherardi RK.

Toxicology. 2018 Dec 1;410:170. doi: 10.1016/j.tox.2018.10.017. No abstract available.

PMID:
30389051
7.

Letter To Editor.

Crépeaux G, Gherardi RK.

Toxicology. 2018 Dec 1;410:166-167. doi: 10.1016/j.tox.2018.06.007. Epub 2018 Jul 6. No abstract available.

PMID:
29908942
8.

Animal studies are mandatory to investigate the poorly understood fate and effects of aluminum adjuvants administered to billions of humans and animals worldwide.

Gherardi RK, Crépeaux G, Authier FJ, Lujan L.

Autoimmun Rev. 2018 Jul;17(7):735-737. doi: 10.1016/j.autrev.2018.02.005. Epub 2018 May 2. No abstract available.

PMID:
29729447
9.

RETRACTED: Letter to the editor "[Toxicology (2017) 159 -159].

Crépeaux G, Exley C, Shaw CA, Gherardi RK.

Toxicology. 2018 Apr 1;398-399:68. doi: 10.1016/j.tox.2018.03.005. No abstract available.

PMID:
29576342
10.

ASIA, chronic fatigue syndrome, and selective low dose neurotoxicity of aluminum adjuvants.

Crépeaux G, Gherardi RK, Authier FJ.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):707. doi: 10.1016/j.jaip.2017.10.039. No abstract available.

PMID:
29525002
11.

Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis.

Aouizerate J, De Antonio M, Bader-Meunier B, Barnerias C, Bodemer C, Isapof A, Quartier P, Melki I, Charuel JL, Bassez G, Desguerre I, Gherardi RK, Authier FJ, Gitiaux C.

Rheumatology (Oxford). 2018 May 1;57(5):873-879. doi: 10.1093/rheumatology/kex516.

PMID:
29474663
12.

Critical analysis of reference studies on the toxicokinetics of aluminum-based adjuvants.

Masson JD, Crépeaux G, Authier FJ, Exley C, Gherardi RK.

J Inorg Biochem. 2018 Apr;181:87-95. doi: 10.1016/j.jinorgbio.2017.12.015. Epub 2017 Dec 28. Review.

PMID:
29307441
13.

Clinical and Neurobehavioral Features of Three Novel Kabuki Syndrome Patients with Mosaic KMT2D Mutations and a Review of Literature.

Lepri FR, Cocciadiferro D, Augello B, Alfieri P, Pes V, Vancini A, Caciolo C, Squeo GM, Malerba N, Adipietro I, Novelli A, Sotgiu S, Gherardi R, Digilio MC, Dallapiccola B, Merla G.

Int J Mol Sci. 2017 Dec 28;19(1). pii: E82. doi: 10.3390/ijms19010082.

14.

Cognitive dysfunction associated with aluminum hydroxide-induced macrophagic myofasciitis: A reappraisal of neuropsychological profile.

Aoun Sebaiti M, Kauv P, Charles-Nelson A, Van Der Gucht A, Blanc-Durand P, Itti E, Gherardi RK, Bachoud-Levi AC, Authier FJ.

J Inorg Biochem. 2018 Apr;181:132-138. doi: 10.1016/j.jinorgbio.2017.09.019. Epub 2017 Oct 6.

PMID:
29079320
15.

Predictive value of brain 18F-FDG PET/CT in macrophagic myofasciitis?: A case report.

Van Der Gucht A, Abulizi M, Blanc-Durand P, Aoun-Sebaiti M, Emsen B, Gherardi RK, Verger A, Authier FJ, Itti E.

Medicine (Baltimore). 2017 Sep;96(39):e8134. doi: 10.1097/MD.0000000000008134.

16.

Letter to the editor.

Crépeaux G, Exley C, Shaw CA, Gherardi RK.

Toxicology. 2017 Sep 1;390:159. doi: 10.1016/j.tox.2017.09.010. Epub 2017 Sep 18. No abstract available. Retraction in: Toxicology. 2018 Apr 1;398-399:68. Toxicology. 2018 Dec 1;410:170.

PMID:
28928034
17.

[Critical analysis of reference studies on aluminium-based adjuvants toxicokinetics].

Masson JD, Crépeaux G, Authier FJ, Exley C, Gherardi RK.

Ann Pharm Fr. 2017 Jul;75(4):245-256. doi: 10.1016/j.pharma.2017.04.004. Epub 2017 May 31. Review. French.

PMID:
28576261
18.

Ischemic myopathy revealing systemic calciphylaxis.

Aouizerate J, Valleyrie-Allanore L, Limal N, Ayache SS, Gherardi RK, Audard V, Jerôme Authier F.

Muscle Nerve. 2017 Sep;56(3):529-533. doi: 10.1002/mus.25505. Epub 2017 Apr 23.

PMID:
27935078
19.

Non-linear dose-response of aluminium hydroxide adjuvant particles: Selective low dose neurotoxicity.

Crépeaux G, Eidi H, David MO, Baba-Amer Y, Tzavara E, Giros B, Authier FJ, Exley C, Shaw CA, Cadusseau J, Gherardi RK.

Toxicology. 2017 Jan 15;375:48-57. doi: 10.1016/j.tox.2016.11.018. Epub 2016 Nov 28.

PMID:
27908630
20.

Brain 18F-FDG PET Metabolic Abnormalities in Patients with Long-Lasting Macrophagic Myofascitis.

Van Der Gucht A, Aoun Sebaiti M, Guedj E, Aouizerate J, Yara S, Gherardi RK, Evangelista E, Chalaye J, Cottereau AS, Verger A, Bachoud-Levi AC, Abulizi M, Itti E, Authier FJ.

J Nucl Med. 2017 Mar;58(3):492-498. doi: 10.2967/jnumed.114.151878. Epub 2016 Oct 20.

21.

Aluminum adjuvants of vaccines injected into the muscle: Normal fate, pathology and associated disease.

Gherardi RK, Aouizerate J, Cadusseau J, Yara S, Authier FJ.

Morphologie. 2016 Jun;100(329):85-94. doi: 10.1016/j.morpho.2016.01.002. Epub 2016 Apr 6. Review.

PMID:
26948677
22.

FDG-PET/CT Brain Findings in a Patient With Macrophagic Myofasciitis.

Van Der Gucht A, Aoun-Sebaiti M, Kauv P, Guedj E, Aouizerate J, Verger A, Gherardi RK, Bachoud-Levi AC, Authier FJ, Itti E.

Nucl Med Mol Imaging. 2016 Mar;50(1):80-4. doi: 10.1007/s13139-015-0371-z. Epub 2015 Sep 23.

23.

Inactivation of Pif1 helicase causes a mitochondrial myopathy in mice.

Bannwarth S, Berg-Alonso L, Augé G, Fragaki K, Kolesar JE, Lespinasse F, Lacas-Gervais S, Burel-Vandenbos F, Villa E, Belmonte F, Michiels JF, Ricci JE, Gherardi R, Harrington L, Kaufman BA, Paquis-Flucklinger V.

Mitochondrion. 2016 Sep;30:126-37. doi: 10.1016/j.mito.2016.02.005. Epub 2016 Feb 24.

24.

Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study.

Dogan C, De Antonio M, Hamroun D, Varet H, Fabbro M, Rougier F, Amarof K, Arne Bes MC, Bedat-Millet AL, Behin A, Bellance R, Bouhour F, Boutte C, Boyer F, Campana-Salort E, Chapon F, Cintas P, Desnuelle C, Deschamps R, Drouin-Garraud V, Ferrer X, Gervais-Bernard H, Ghorab K, Laforet P, Magot A, Magy L, Menard D, Minot MC, Nadaj-Pakleza A, Pellieux S, Pereon Y, Preudhomme M, Pouget J, Sacconi S, Sole G, Stojkovich T, Tiffreau V, Urtizberea A, Vial C, Zagnoli F, Caranhac G, Bourlier C, Riviere G, Geille A, Gherardi RK, Eymard B, Puymirat J, Katsahian S, Bassez G.

PLoS One. 2016 Feb 5;11(2):e0148264. doi: 10.1371/journal.pone.0148264. eCollection 2016.

25.

Dermatomyositis: factors predicting relapse.

Vuong V, Duong TA, Aouizerate J, Authier FJ, Ingen-Housz-Oro S, Valeyrie-Allanore L, Ortonne N, Wolkenstein P, Gherardi RK, Chosidow O, Cosnes A, Sbidian E.

J Eur Acad Dermatol Venereol. 2016 May;30(5):813-8. doi: 10.1111/jdv.13516. Epub 2015 Dec 15.

PMID:
26670098
26.

Late onset dysferlinopathy mimicking treatment resistant polymyositis.

Griger Z, Nagy-Vincze M, Bodoki L, Gherardi RK, Dankó K, Hortobágyi T.

Joint Bone Spine. 2016 May;83(3):355-6. doi: 10.1016/j.jbspin.2015.03.017. Epub 2015 Oct 21. No abstract available.

PMID:
26471412
27.

Expanding the clinical spectrum of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis due to FAM111B mutations.

Mercier S, Küry S, Salort-Campana E, Magot A, Agbim U, Besnard T, Bodak N, Bou-Hanna C, Bréhéret F, Brunelle P, Caillon F, Chabrol B, Cormier-Daire V, David A, Eymard B, Faivre L, Figarella-Branger D, Fleurence E, Ganapathi M, Gherardi R, Goldenberg A, Hamel A, Igual J, Irvine AD, Israël-Biet D, Kannengiesser C, Laboisse C, Le Caignec C, Mahé JY, Mallet S, MacGowan S, McAleer MA, McLean I, Méni C, Munnich A, Mussini JM, Nagy PL, Odel J, O'Regan GM, Péréon Y, Perrier J, Piard J, Puzenat E, Sampson JB, Smith F, Soufir N, Tanji K, Thauvin C, Ulane C, Watson RM, Khumalo NP, Mayosi BM, Barbarot S, Bézieau S.

Orphanet J Rare Dis. 2015 Oct 15;10:135. doi: 10.1186/s13023-015-0352-4.

28.

Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis.

Gitiaux C, De Antonio M, Aouizerate J, Gherardi RK, Guilbert T, Barnerias C, Bodemer C, Brochard-Payet K, Quartier P, Musset L, Chazaud B, Desguerre I, Bader-Meunier B.

Rheumatology (Oxford). 2016 Mar;55(3):470-9. doi: 10.1093/rheumatology/kev359. Epub 2015 Sep 30.

PMID:
26424834
29.

Highly delayed systemic translocation of aluminum-based adjuvant in CD1 mice following intramuscular injections.

Crépeaux G, Eidi H, David MO, Tzavara E, Giros B, Exley C, Curmi PA, Shaw CA, Gherardi RK, Cadusseau J.

J Inorg Biochem. 2015 Nov;152:199-205. doi: 10.1016/j.jinorgbio.2015.07.004. Epub 2015 Jul 22.

PMID:
26384437
30.

Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.

Mescam-Mancini L, Allenbach Y, Hervier B, Devilliers H, Mariampillay K, Dubourg O, Maisonobe T, Gherardi R, Mezin P, Preusse C, Stenzel W, Benveniste O.

Brain. 2015 Sep;138(Pt 9):2485-92. doi: 10.1093/brain/awv192. Epub 2015 Jul 21.

PMID:
26198592
31.

Fluorescent nanodiamonds as a relevant tag for the assessment of alum adjuvant particle biodisposition.

Eidi H, David MO, Crépeaux G, Henry L, Joshi V, Berger MH, Sennour M, Cadusseau J, Gherardi RK, Curmi PA.

BMC Med. 2015 Jun 17;13:144. doi: 10.1186/s12916-015-0388-2.

32.

Neuropsychological Correlates of Brain Perfusion SPECT in Patients with Macrophagic Myofasciitis.

Van Der Gucht A, Aoun Sebaiti M, Itti E, Aouizerate J, Evangelista E, Chalaye J, Gherardi RK, Ragunathan-Thangarajah N, Bachoud-Levi AC, Authier FJ.

PLoS One. 2015 Jun 1;10(6):e0128353. doi: 10.1371/journal.pone.0128353. eCollection 2015.

33.

Pericytes in the myovascular niche promote post-natal myofiber growth and satellite cell quiescence.

Kostallari E, Baba-Amer Y, Alonso-Martin S, Ngoh P, Relaix F, Lafuste P, Gherardi RK.

Development. 2015 Apr 1;142(7):1242-53. doi: 10.1242/dev.115386. Epub 2015 Mar 5.

34.

Th2-M2 immunity in lesions of muscular sarcoidosis and macrophagic myofasciitis.

Preusse C, Goebel HH, Pehl D, Rinnenthal JL, Kley RA, Allenbach Y, Heppner FL, Vorgerd M, Authier FJ, Gherardi R, Stenzel W.

Neuropathol Appl Neurobiol. 2015 Dec;41(7):952-63. doi: 10.1111/nan.12231. Epub 2015 May 19.

PMID:
25711697
35.

Biopersistence and brain translocation of aluminum adjuvants of vaccines.

Gherardi RK, Eidi H, Crépeaux G, Authier FJ, Cadusseau J.

Front Neurol. 2015 Feb 5;6:4. doi: 10.3389/fneur.2015.00004. eCollection 2015. Review.

36.

205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies part II 28-30 March 2014, Naarden, The Netherlands.

De Bleecker JL, De Paepe B, Aronica E, de Visser M; ENMC Myositis Muscle Biopsy Study Group, Amato A, Aronica E, Benveniste O, De Bleecker J, de Boer O, De Paepe B, de Visser M, Dimachkie M, Gherardi R, Goebel HH, Hilton-Jones D, Holton J, Lundberg IE, Mammen A, Mastaglia F, Nishino I, Rushing E, Schroder HD, Selcen D, Stenzel W.

Neuromuscul Disord. 2015 Mar;25(3):268-72. doi: 10.1016/j.nmd.2014.12.001. Epub 2014 Dec 10. No abstract available.

PMID:
25572016
37.

Clinical features in patients with long-lasting macrophagic myofasciitis.

Rigolet M, Aouizerate J, Couette M, Ragunathan-Thangarajah N, Aoun-Sebaiti M, Gherardi RK, Cadusseau J, Authier FJ.

Front Neurol. 2014 Nov 28;5:230. doi: 10.3389/fneur.2014.00230. eCollection 2014. Review.

38.

Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy.

Aouizerate J, De Antonio M, Bassez G, Gherardi RK, Berenbaum F, Guillevin L, Berezne A, Valeyre D, Maisonobe T, Dubourg O, Cosnes A, Benveniste O, Authier FJ.

Acta Neuropathol Commun. 2014 Oct 23;2:154. doi: 10.1186/s40478-014-0154-2.

39.

[Biopersistence and systemic distribution of intramuscularly injected particles: what impact on long-term tolerability of alum adjuvants?].

Gherardi RK, Cadusseau J, Authier FJ.

Bull Acad Natl Med. 2014 Jan;198(1):37-48; discussion 49-53. French.

PMID:
26259285
40.

Mutations in FAM111B cause hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis.

Mercier S, Küry S, Shaboodien G, Houniet DT, Khumalo NP, Bou-Hanna C, Bodak N, Cormier-Daire V, David A, Faivre L, Figarella-Branger D, Gherardi RK, Glen E, Hamel A, Laboisse C, Le Caignec C, Lindenbaum P, Magot A, Munnich A, Mussini JM, Pillay K, Rahman T, Redon R, Salort-Campana E, Santibanez-Koref M, Thauvin C, Barbarot S, Keavney B, Bézieau S, Mayosi BM.

Am J Hum Genet. 2013 Dec 5;93(6):1100-7. doi: 10.1016/j.ajhg.2013.10.013. Epub 2013 Nov 21.

41.

Selective elevation of circulating CCL2/MCP1 levels in patients with longstanding post-vaccinal macrophagic myofasciitis and ASIA.

Cadusseau J, Ragunathan-Thangarajah N, Surenaud M, Hue S, Authier FJ, Gherardi RK.

Curr Med Chem. 2014;21(4):511-7.

42.

Distinctive clinical features in arthro-myalgic patients with and without aluminum hydroxyde-induced macrophagic myofasciitis: an exploratory study.

Ragunathan-Thangarajah N, Le Beller C, Boutouyrie P, Bassez G, Gherardi RK, Laurent S, Authier FJ.

J Inorg Biochem. 2013 Nov;128:262-6. doi: 10.1016/j.jinorgbio.2013.07.020. Epub 2013 Jul 20.

PMID:
23921285
43.

Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease.

Virgone-Carlotta A, Uhlrich J, Akram MN, Ressnikoff D, Chrétien F, Domenget C, Gherardi R, Despars G, Jurdic P, Honnorat J, Nataf S, Touret M.

Glia. 2013 Oct;61(10):1645-58. doi: 10.1002/glia.22546. Epub 2013 Jul 25.

PMID:
23893349
44.

Dual effects of exercise in dysferlinopathy.

Biondi O, Villemeur M, Marchand A, Chretien F, Bourg N, Gherardi RK, Richard I, Authier FJ.

Am J Pathol. 2013 Jun;182(6):2298-309. doi: 10.1016/j.ajpath.2013.02.045. Epub 2013 Apr 24.

PMID:
23624156
45.

Juvenile dermatomyositis.

Quartier P, Gherardi RK.

Handb Clin Neurol. 2013;113:1457-63. doi: 10.1016/B978-0-444-59565-2.00014-9. Review.

PMID:
23622367
46.

Slow CCL2-dependent translocation of biopersistent particles from muscle to brain.

Khan Z, Combadière C, Authier FJ, Itier V, Lux F, Exley C, Mahrouf-Yorgov M, Decrouy X, Moretto P, Tillement O, Gherardi RK, Cadusseau J.

BMC Med. 2013 Apr 4;11:99. doi: 10.1186/1741-7015-11-99.

47.

Genetic and clinical specificity of 26 symptomatic carriers for dystrophinopathies at pediatric age.

Mercier S, Toutain A, Toussaint A, Raynaud M, de Barace C, Marcorelles P, Pasquier L, Blayau M, Espil C, Parent P, Journel H, Lazaro L, Andoni Urtizberea J, Moerman A, Faivre L, Eymard B, Maincent K, Gherardi R, Chaigne D, Ben Yaou R, Leturcq F, Chelly J, Desguerre I.

Eur J Hum Genet. 2013 Aug;21(8):855-63. doi: 10.1038/ejhg.2012.269. Epub 2013 Jan 9. Erratum in: Eur J Hum Genet. 2013 Aug;21(8):892.

48.

Macrophages improve survival, proliferation and migration of engrafted myogenic precursor cells into MDX skeletal muscle.

Lesault PF, Theret M, Magnan M, Cuvellier S, Niu Y, Gherardi RK, Tremblay JP, Hittinger L, Chazaud B.

PLoS One. 2012;7(10):e46698. doi: 10.1371/journal.pone.0046698. Epub 2012 Oct 2.

49.

Whole microvascular unit deletions in dermatomyositis.

Gitiaux C, Kostallari E, Lafuste P, Authier FJ, Christov C, Gherardi RK.

Ann Rheum Dis. 2013 Mar;72(3):445-52. doi: 10.1136/annrheumdis-2012-201822. Epub 2012 Sep 8.

PMID:
22962315
50.

Re: assessinq competence to practice.

Gherardi RJ.

J Am Coll Dent. 2012 Spring;79(1):5; author reply 10. No abstract available.

PMID:
22856042

Supplemental Content

Loading ...
Support Center